U.S. Physical Therapy, Inc. (NYSE:USPH) Director Sells $116,000.00 in Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) Director Mark J. Brookner sold 1,000 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $116.00, for a total transaction of $116,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Mark J. Brookner also recently made the following trade(s):

  • On Thursday, November 21st, Mark J. Brookner sold 1,000 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $116.25, for a total transaction of $116,250.00.

NYSE USPH opened at $116.86 on Monday. The company has a market capitalization of $1.50 billion, a PE ratio of 44.10, a P/E/G ratio of 3.34 and a beta of 1.09. The company has a fifty day moving average of $129.00 and a 200 day moving average of $126.57. U.S. Physical Therapy, Inc. has a 1 year low of $98.69 and a 1 year high of $148.48. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 1.47.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Thursday, November 7th. The company reported $0.71 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.71. The company had revenue of $117.30 million during the quarter, compared to the consensus estimate of $121.28 million. U.S. Physical Therapy had a net margin of 6.36% and a return on equity of 16.57%. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.64 earnings per share. Research analysts expect that U.S. Physical Therapy, Inc. will post 2.86 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 18th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.03%. U.S. Physical Therapy’s dividend payout ratio is presently 45.28%.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in USPH. Louisiana State Employees Retirement System increased its stake in shares of U.S. Physical Therapy by 2.1% during the second quarter. Louisiana State Employees Retirement System now owns 4,800 shares of the company’s stock worth $616,000 after purchasing an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in U.S. Physical Therapy by 2.0% during the 2nd quarter. Oregon Public Employees Retirement Fund now owns 5,013 shares of the company’s stock valued at $614,000 after acquiring an additional 100 shares in the last quarter. AE Wealth Management LLC grew its stake in U.S. Physical Therapy by 61.4% during the 2nd quarter. AE Wealth Management LLC now owns 4,369 shares of the company’s stock valued at $536,000 after acquiring an additional 1,662 shares in the last quarter. Arizona State Retirement System grew its stake in U.S. Physical Therapy by 1.2% during the 2nd quarter. Arizona State Retirement System now owns 19,795 shares of the company’s stock valued at $2,426,000 after acquiring an additional 227 shares in the last quarter. Finally, Bridge City Capital LLC grew its stake in U.S. Physical Therapy by 0.5% during the 2nd quarter. Bridge City Capital LLC now owns 34,741 shares of the company’s stock valued at $4,258,000 after acquiring an additional 171 shares in the last quarter.

A number of research firms recently issued reports on USPH. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Thursday. Barrington Research upgraded shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 target price for the company in a research report on Friday, November 8th. Finally, ValuEngine upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating in a research report on Friday, November 1st. One analyst has rated the stock with a sell rating and three have given a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $127.20.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More: Trading on Margin

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.